RXRX
USDRecursion Pharmaceuticals Inc. Class A Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$5.200
Máximo
$5.320
Mínimo
$4.970
Volumen
57.15M
Fundamentos de la Empresa
Capitalización de Mercado
2.2B
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
39.05M
Bolsa
NMS
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Recursion to Participate in Upcoming Investor Conferences
Salt Lake City, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following
Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th
Salt Lake City, UT, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and
Buybacks take backseat as AI drives record US capex spending
Investors are increasingly favoring U.S. companies that channel capital toward AI innovation over those offering traditional shareholder payouts such as dividends and buybacks, even as the debate over soaring valuations and an AI bubble rages on.
Acciones Relacionadas
HPE
Hewlett Packard Enterprise Company
CDE
Coeur Mining Inc.
GTBP
GT Biopharma Inc.
VIASP
Via Renewables Inc. 8.75% Series A Fixed-to-Floating Rate Cumulative Redeemable Perpetual Preferred Stock
JLL
Jones Lang LaSalle Incorporated
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.